James S Scibetta
CIK 1383242 · Lihat di SEC EDGAR ↗
Orang Dalam
Pengajuan SEC Pertama: 24 Juli 2018 · Terbaru: 24 Juli 2018
Di halaman ini
- Orang Dalam di Perusahaan di mana orang ini adalah orang dalam yang melaporkan.
- Transaksi orang dalam Setiap saham yang dibeli atau dijual orang ini, dari pengajuan Formulir 4.
- Derivatif Opsi dan kepemilikan derivatif lainnya yang dilaporkan oleh orang ini.
- Kepemilikan Awal Kepemilikan yang dimiliki orang ini saat pertama kali mulai melaporkan.
- Kompensasi Gaji eksekutif yang diungkapkan dalam pernyataan proksi perusahaan.
Orang Dalam di
Transaksi orang dalam
0 beli (P)
0 jual (S)
Bersih:
$0
+ 49 transaksi non-pasar di bawah
12 bulan terakhir, berdasarkan transaksi yang ditunjukkan di bawah ini
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
49 pengajuan lain disembunyikan
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 21 Agu 2019 | AQST | P | 900 | $3,81 | $3.429 | 31.635 Langsung | +2,93% | Diakuisisi | 19,4% (harga per 2026-08-20) |
| 20 Agu 2019 | AQST | P | 11.310 | $3,80 | $42.978 | 30.735 Langsung | +58,22% | Diakuisisi | 19,7% (harga per 2026-08-20) |
| 19 Agu 2019 | AQST | P | 10.761 | $3,77 | $40.569 | 19.425 Langsung | +124,20% | Diakuisisi | 20,7% (harga per 2026-08-20) |
| 5 Juni 2017 | PCRX | S | 1.966 | $43,32 | $85.167 | 25.118 Langsung | -7,26% | Dilepas | -44,4% (harga per 2026-08-20) |
| 15 Mei 2017 | PCRX | S 10b5-1 | 20.000 | $51,20 | $1.024.000 | 27.084 Langsung | -42,48% | Dilepas | -53,0% (harga per 2026-08-20) |
| 17 Jan. 2017 | PCRX | S 10b5-1 | 4.997 | $38,97 | $194.733 | 27.084 Langsung | -15,58% | Dilepas | -38,2% (harga per 2026-08-20) |
| 17 Jan. 2017 | PCRX | S 10b5-1 | 15.003 | $38,39 | $575.965 | 32.081 Langsung | -31,86% | Dilepas | -37,3% (harga per 2026-08-20) |
| 15 Nov. 2016 | PCRX | S 10b5-1 | 20.000 | $36,50 | $730.000 | 27.084 Langsung | -42,48% | Dilepas | -34,0% (harga per 2026-08-20) |
| 15 Agu 2016 | PCRX | S 10b5-1 | 25.000 | $45,21 | $1.130.250 | 27.084 Langsung | -48,00% | Dilepas | -46,7% (harga per 2026-08-20) |
| 11 Sep. 2015 | PCRX | P | 5.000 | $61,37 | $306.850 | 10.504 Langsung | +90,84% | Diakuisisi | -60,8% (harga per 2026-08-20) |
| 6 Feb. 2015 | PCRX | S 10b5-1 | 1.700 | $112,91 | $191.947 | 5.230 Langsung | -24,53% | Dilepas | -78,7% (harga per 2026-08-20) |
| 6 Feb. 2015 | PCRX | S 10b5-1 | 3.103 | $111,98 | $347.474 | 6.930 Langsung | -30,93% | Dilepas | -78,5% (harga per 2026-08-20) |
| 6 Feb. 2015 | PCRX | S 10b5-1 | 5.904 | $111,11 | $655.993 | 10.033 Langsung | -37,05% | Dilepas | -78,3% (harga per 2026-08-20) |
| 6 Feb. 2015 | PCRX | S 10b5-1 | 4.293 | $110,17 | $472.960 | 15.937 Langsung | -21,22% | Dilepas | -78,1% (harga per 2026-08-20) |
| 7 Nov. 2014 | PCRX | S 10b5-1 | 200 | $90,33 | $18.066 | 5.000 Langsung | -3,85% | Dilepas | -73,3% (harga per 2026-08-20) |
| 7 Nov. 2014 | PCRX | S 10b5-1 | 800 | $89,56 | $71.648 | 5.200 Langsung | -13,33% | Dilepas | -73,1% (harga per 2026-08-20) |
| 7 Nov. 2014 | PCRX | S 10b5-1 | 3.100 | $87,65 | $271.715 | 6.000 Langsung | -34,07% | Dilepas | -72,5% (harga per 2026-08-20) |
| 7 Nov. 2014 | PCRX | S 10b5-1 | 8.600 | $86,99 | $748.114 | 9.100 Langsung | -48,59% | Dilepas | -72,3% (harga per 2026-08-20) |
| 7 Nov. 2014 | PCRX | S 10b5-1 | 2.300 | $86,13 | $198.099 | 17.700 Langsung | -11,50% | Dilepas | -72,0% (harga per 2026-08-20) |
| 8 Agu 2014 | PCRX | S 10b5-1 | 10.000 | $99,83 | $998.300 | 5.000 Langsung | -66,67% | Dilepas | -75,9% (harga per 2026-08-20) |
| 8 Agu 2014 | PCRX | S 10b5-1 | 5.000 | $99,22 | $496.100 | 15.000 Langsung | -25,00% | Dilepas | -75,7% (harga per 2026-08-20) |
| 8 Mei 2014 | PCRX | S 10b5-1 | 300 | $75,80 | $22.740 | 5.000 Langsung | -5,66% | Dilepas | -68,2% (harga per 2026-08-20) |
| 8 Mei 2014 | PCRX | S 10b5-1 | 11.400 | $75,25 | $857.850 | 5.300 Langsung | -68,26% | Dilepas | -68,0% (harga per 2026-08-20) |
| 8 Mei 2014 | PCRX | S 10b5-1 | 3.300 | $74,27 | $245.091 | 16.700 Langsung | -16,50% | Dilepas | -67,6% (harga per 2026-08-20) |
| 30 Des. 2013 | PCRX | S 10b5-1 | 10.000 | $55,55 | $555.500 | 5.000 Langsung | -66,67% | Dilepas | -56,6% (harga per 2026-08-20) |
| 30 Sep. 2013 | PCRX | S 10b5-1 | 10.000 | $46,74 | $467.400 | 5.000 Langsung | -66,67% | Dilepas | -48,5% (harga per 2026-08-20) |
| 28 Juni 2013 | PCRX | S 10b5-1 | 10.000 | $28,05 | $280.500 | 5.000 Langsung | -66,67% | Dilepas | -14,1% (harga per 2026-08-20) |
| 28 Maret 2013 | PCRX | S 10b5-1 | 10.000 | $28,49 | $284.900 | 5.000 Langsung | -66,67% | Dilepas | -15,5% (harga per 2026-08-20) |
| 15 Feb. 2011 | PCRX | P | 5.000 | $7,04 | $35.200 | 5.000 Langsung | — | Diakuisisi | 242,1% (harga per 2026-08-20) |
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II)
Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 15 Juni 2021 | AQST | Stock Option (Right to Purchase) | Common Stock (20.000) | $4,04 | 15 Juni 2031 | 20.000 | Diakuisisi |
| 16 Juni 2020 | AQST | Stock Option (Right to Purchase) | Common Stock (14.000) | $5,30 | 16 Juni 2030 | 14.000 | Diakuisisi |
| 13 Juni 2019 | AQST | Stock Option (Right to Purchase) | Common Stock (13.350) | $4,38 | 13 Juni 2029 | 13.350 | Diakuisisi |
| 24 Juli 2018 | AQST | Stock Option (Right to Purchase) | Common Stock (26.700) | $15,00 | 24 Juli 2028 | 26.700 | Diakuisisi |
| 15 Mei 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (20.000) | $5,49 | 29 Des. 2020 | 20.000 | Dilepas |
| 17 Jan. 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (17.627) | $5,49 | 29 Des. 2020 | 17.627 | Dilepas |
| 17 Jan. 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (2.373) | $1,61 | 2 Sep. 2020 | 2.373 | Dilepas |
| 7 Des. 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (20.000) | $32,35 | 7 Des. 2026 | 20.000 | Diakuisisi |
| 15 Nov. 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (20.000) | $1,61 | 2 Sep. 2020 | 20.000 | Dilepas |
| 15 Agu 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (9.123) | $1,61 | 2 Sep. 2020 | 9.123 | Dilepas |
| 15 Agu 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (15.877) | $1,61 | 2 Sep. 2020 | 15.877 | Dilepas |
| 15 Juni 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (32.500) | $40,34 | 15 Juni 2026 | 32.500 | Diakuisisi |
| 3 Nov. 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (40.000) | $55,34 | 3 Nov. 2025 | 40.000 | Diakuisisi |
| 6 Feb. 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (15.000) | $1,61 | 2 Sep. 2020 | 15.000 | Dilepas |
| 7 Nov. 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (15.000) | $1,61 | 2 Sep. 2020 | 15.000 | Dilepas |
| 8 Agu 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (6.134) | $1,61 | 2 Sep. 2020 | 6.134 | Dilepas |
| 8 Agu 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (8.866) | $1,61 | 2 Sep. 2020 | 8.866 | Dilepas |
| 3 Juni 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (70.000) | $81,00 | 3 Juni 2024 | 70.000 | Diakuisisi |
| 8 Mei 2014 | PCRX | Employee Stock Option (right to buy) | Common Stock (15.000) | $1,61 | 2 Sep. 2020 | 15.000 | Dilepas |
| 31 Des. 2013 | NEPH | Non-Qualified Stock Option (right to buy) | Common Stock (60.440) | $0,42 | 31 Des. 2023 | 60.440 | Diakuisisi |
| 30 Des. 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock (10.000) | $1,61 | 2 Sep. 2020 | 10.000 | Dilepas |
| 30 Sep. 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock (10.000) | $1,61 | 2 Sep. 2020 | 10.000 | Dilepas |
| 28 Juni 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock (10.000) | $1,61 | 2 Sep. 2020 | 10.000 | Dilepas |
| 23 Mei 2013 | NEPH | Non-Qualified Stock Option (right to buy) | Common Stock (12.500) | $0,71 | 23 Mei 2023 | 12.500 | Diakuisisi |
| 28 Maret 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock (10.000) | $1,61 | 2 Sep. 2020 | 10.000 | Dilepas |
| 5 Juni 2012 | PCRX | Common Stock | Common Stock (150.000) | $10,81 | 4 Juni 2022 | 150.000 | Diakuisisi |
| 16 Feb. 2012 | NEPH | Non-Qualified Stock Option (right to buy) | Common Stock (12.500) | $0,83 | 16 Feb. 2022 | 12.500 | Diakuisisi |
| 24 Maret 2011 | NEPH | Non-qualified stock option (right to buy) | Common Stock (60.000) | $0,51 | 24 Maret 2021 | 60.000 | Diakuisisi |
| 8 Jan. 2010 | NEPH | Non-qualified stock option (right to buy) | Common Stock (22.500) | $0,95 | 8 Jan. 2020 | 22.500 | Diakuisisi |
| 17 Agu 2009 | NEPH | Non-qualified stock option (right to buy) | Common Stock (20.000) | $1,71 | 17 Agu 2019 | 20.000 | Diakuisisi |
| 30 Nov. 2007 | NEPH | Non-qualified stock option (right to buy) | Common Stock (20.000) | $0,80 | 30 Nov. 2017 | 20.000 | Diakuisisi |
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kepemilikan Awal (Formulir 3) 4 saham
Sekuritas yang dipegang saat pertama kali menjadi orang dalam, sesuai Formulir 3 SEC.
| Tanggal | Ticker | Sekuritas | Saham | Kepemilikan |
|---|---|---|---|---|
| 24 Juli 2018 | AQST | Common Stock [F1] | 8.664 | Langsung |
| 2 Feb. 2011 | PCRX | Stock Option (Right to Buy)→ Common Stock (74.384) | 74.384 | Langsung |
| 2 Feb. 2011 | PCRX | Stock Option (Right to Buy)→ Common Stock (72.989) | 72.989 | Langsung |
| 2 Feb. 2011 | PCRX | Stock Option (Right to Buy)→ Common Stock (52.877) | 52.877 | Langsung |
Kompensasi (DEF 14A)
Dicocokkan berdasarkan nama dari pernyataan proksi (DEF 14A) — verifikasi terhadap pengajuan.
| Tahun fiskal | Gaji | Bonus | Penghargaan saham | Penghargaan opsi | Insentif non-ekuitas | Perubahan Pensiun | Lainnya | Total |
|---|---|---|---|---|---|---|---|---|
| 2016 | $494.231 | $198.000 | $655.525 | $980.572 | — | — | $966 | $2.329.294 |
| 2015 | $409.091 | $237.500 | — | $1.091.868 | — | — | $966 | $1.739.425 |
| 2014 | $369.253 | $165.000 | — | $2.980.099 | — | — | $966 | $3.515.318 |
Angka-angka dari Tabel Kompensasi Ringkasan dalam pernyataan proksi perusahaan (DEF 14A). Kompensasi bukan merupakan rekomendasi.